|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02197 CLOVER BIO-B
Nominal 
0.730 -0.040 (-5.195%) | 2022/12 - Final RMB(¥) | 2021/12 RMB(¥) | 2020/12 RMB(¥) | 2019/12 RMB(¥) | ||
| Net Cash from / (used in) Operating Activities | -- | (917,749,000) | 476,927,000 | (26,617,000) | |
| Net Cash from / (used in) Investing Activities | -- | 112,124,000 | (394,120,000) | (2,598,000) | |
| Net Cash from / (used in) Financing Activities | -- | 3,057,173,000 | 316,847,000 | 142,050,000 | |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 2,251,548,000 | 399,654,000 | 112,835,000 | |
| Cash & Cash Equivalents at beginning of period | -- | 516,184,000 | 148,694,000 | 35,744,000 | |
| Effect of Foreign Exchange Rate Changes | -- | (361,000) | (32,164,000) | 115,000 | |
| Others | -- | 0 | 0 | 0 | |
| Cash & Cash Equivalents at end of period | -- | 2,767,371,000 | 516,184,000 | 148,694,000 |
| Remarks: | Real time quote last updated: 03/10/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 650,624,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.520 |
| NBV Per Share (¥) | RMB 0.022 |